Loading...

Two-year results of intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation

AIM: To clarify the 2-year efficacy of ranibizumab for patients with polypoidal choroidal vasculopathy (PCV) with recurrent or residual exudation from branching vascular networks after previous photodynamic therapy (PDT). METHODS: We retrospectively reviewed 26 eyes of 26 Japanese patients (22 men,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Saito, M, Iida, T, Kano, M, Itagaki, K
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2013
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3740310/
https://ncbi.nlm.nih.gov/pubmed/23743532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2013.114
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!